2019 Clinic Diagnosis Lab Testing 
FDA Law Blog
JANUARY 6, 2022
In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs Haw., 18 U.S.C. § 18 U.S.C. § 18 U.S.C. § 220(b)(2). Background Facts.
FDA Law Blog
JANUARY 6, 2022
In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs Haw., 18 U.S.C. § 18 U.S.C. § 18 U.S.C. § 220(b)(2). Background Facts.
Expert insights. Personalized for you.
52 
Let's personalize your content